Abstract
Numerous reports of neuropsychiatric symptoms highlighted the pathologic potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its relationship the onset and/or exacerbation of mental disease. However, coronavirus disease 2019 (COVID-19) treatments, themselves, must be considered as potential catalysts for new-onset neuropsychiatric symptoms in COVID-19 patients. To date, immediate and long-term neuropsychiatric complications following SARS-CoV-2 infection are currently unknown. Here we report on five patients with SARS-CoV-2 infection with possible associated neuropsychiatric involvement, following them clinically until resolution of their symptoms. We will also discuss the contributory roles of chloroquine and dexamethasone in these neuropsychiatric presentations.
Keywords: COVID-19; SARS-CoV-2; chloroquine; corticosteroids; neuropsychiatric.
【저자키워드】 COVID-19, SARS-CoV-2, Corticosteroids, Chloroquine, neuropsychiatric., 【초록키워드】 Dexamethasone, coronavirus disease, coronavirus, SARS-COV-2 infection, Infection, Symptom, Symptoms, Complication, Neuropsychiatric, disease, COVID-19 patients, acute respiratory syndrome, Mental, FIVE, pathologic, clinically, Numerous, patients with SARS-CoV-2, 【제목키워드】 Symptom, Neuropsychiatric,